Beschreibung
Tuberculosis continues to be a major infectious cause of global morbidity and mortality, both in children and adults, in spite of widespread vaccination of infants with Bacille Calmette-Guerin (BCG) and the availability of effective antibiotics. The failure of BCG to significantly affect disease incidence in adults in many endemic countries, combined with the growing HIV epidemic and the appearance of multidrug resistant strains of Mycobacterium tuberculosis, threatens to overwhelm current tuberculosis control strategies. This unfortunate state of affairs has driven an intensive search for better tuberculosis vaccines. - DN McMurray. Indian J Pediatr 67 (2 Suppl), S58-S62. 2000
Autorenporträt
Dr. Mathan Periasamy has 11 years of experience in Teaching/Research/Healthcare Sectors of Microbiology & Biotechnology. He has published/presented several research papers in International journals/conferences. His fields of Interest include; Microbial Infections, Immunology of Diseases, Stem Cell Technology and Nanotechnology in Medicine.
